David W. McIlwain

The role of inhibitor of apoptosis (IAP) family member survivin in prostatic disease

David W. McIlwain, 2017 .

Antitumor Activity and Mechanistic Characterization of APE1/Ref-1 Inhibitors in Bladder Cancer

G. Sandusky, M. Kelley, M. Fishel, 2019, Molecular Cancer Therapeutics.

Coordinated induction of cell survival signaling in the inflamed microenvironment of the prostate

Marloes Zoetemelk, T. Jerde, Brandy M. Snider, 2016, The Prostate.

APE1/Ref-1 redox-specific inhibition decreases survivin protein levels and induces cell cycle arrest in prostate cancer cells

M. Kelley, M. Fishel, T. Jerde, 2017, Oncotarget.

Ramucirumab for patients with intermediate-stage hepatocellular carcinoma (HCC) and elevated alpha fetoprotein (AFP): pooled results from two phase 3 studies (REACH and REACH-2)

M. Kudo, P. Galle, K. Rau, 2020, Zeitschrift für Gastroenterologie.

Ramucirumab for Patients with Intermediate-Stage Hepatocellular Carcinoma and Elevated Alpha-Fetoprotein: Pooled Results from Two Phase 3 Studies (REACH and REACH-2)

M. Kudo, P. Galle, K. Rau, 2021, Liver Cancer.